drugset / Trial / NCT01761526
Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
Phase 1
Completed
50 enrolled
UCB BIOSCIENCES, Inc.
40789 Monheim am Rhein · collabAlfred-Nobel-Str. 10 · collabSchwarz BioSciences GmbH · collab
Non-randomizedSingle-groupOpen-label
Summary
To investigate the Pharmacokinetics (PK) of transdermally delivered Rotigotine in Japanese and Caucasian Female and Male Healthy Subjects.
Timeline
- Start
- 2002-10
- Primary completion
- 2002-10
- Completion
- 2002-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rotigotine | Unknown | 2 mg | Other |
Indications
No indication recorded.